Post-Transplant Cyclophosphamide after Bone Marrow Transplantation is not Associated with an Increased Risk of Donor Derived Malignancy

Post-transplant cyclophosphamide (PTCy) can be used for graft versus host disease (GVHD) prophylaxis alone or in combination with other agents and is associated with excellent rates of engraftment, acute and chronic GVHD, and an absence of post-transplant lymphoproliferative disease. No study has pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Majzner, Robbie G., Mogri, Huzefa, Varadhan, Ravi, Brown, Patrick, Cooke, Kenneth R., Bolaños-Meade, Javier, Swinnen, Lode, Kanakry, Jennifer, Luznik, Leo, Jones, Rick, Fuchs, Ephraim, Ambinder, Rich, Kasamon, Yvette, Symons, Heather J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5632950/
https://ncbi.nlm.nih.gov/pubmed/28062216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.12.640
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados